Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000007

CFO and Treasurer sold 2,225 shares at $44.75 ($99,569)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. CFO and Treasurer 2022-01-05 Sale −2,225 $44.75 $99,569 124,077 D
Open-market sales · 2,225 sh · avg $44.75 · $99,569
Loading xslF345X03/wf-form4_164159675294746.xml…